Mark J. Alles - 21 Jun 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc.

Role
Director
Signature
/s/ Annette North, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
21 Jun 2021
Net transactions value
+$162,680
Form type
4
Filing time
21 Jun 2021, 21:14:17 UTC
Previous filing
10 Jun 2021
Next filing
05 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Purchase $162,680 +2,000 $81.34 2,000 21 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.